Virtu Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,288
| Closed | -$5.63M | – | 1731 |
|
|
2024
Q4 | $5.63M | Buy |
7,288
+757
| +12% | +$627K | 0.3% | 45 |
|
|
2024
Q3 | $5.79M | Buy |
6,531
+3,446
| +112% | +$3.1M | 0.32% | 42 |
|
|
2024
Q2 | $2.79M | Buy |
3,085
+336
| +12% | +$269K | 0.19% | 98 |
|
|
2024
Q1 | $2.14M | Buy |
+2,749
| New | +$1.96M | 0.16% | 112 |
|
|
2023
Q4 | – | Sell |
-15,978
| Closed | -$8.58M | – | 1816 |
|
|
2023
Q3 | $8.58M | Buy |
+15,978
| New | +$8.23M | 0.85% | 9 |
|
|
2023
Q1 | – | Sell |
-15,764
| Closed | -$5.77M | – | 1822 |
|
|
2022
Q4 | $5.77M | Buy |
+15,764
| New | +$5.59M | 0.76% | 6 |
|
|
2022
Q3 | – | Sell |
-4,397
| Closed | -$1.43M | – | 1995 |
|
|
2022
Q2 | $1.43M | Buy |
+4,397
| New | +$1.32M | 0.12% | 149 |
|
|
2022
Q1 | – | Sell |
-15,139
| Closed | -$4.18M | – | 1783 |
|
|
2021
Q4 | $4.18M | Buy |
15,139
+12,394
| +452% | +$3.14M | 0.43% | 40 |
|
|
2021
Q3 | $634K | Buy |
+2,745
| New | +$677K | 0.06% | 363 |
|
|
2021
Q2 | – | Sell |
-12,929
| Closed | -$2.42M | – | 1815 |
|
|
2021
Q1 | $2.42M | Buy |
+12,929
| New | +$2.53M | 0.17% | 82 |
|
|
2020
Q4 | – | Sell |
-4,778
| Closed | -$707K | – | 1626 |
|
|
2020
Q3 | $707K | Buy |
+4,778
| New | +$739K | 0.12% | 195 |
|
|
2019
Q4 | $2.72M | Buy |
20,703
+8,102
| +64% | +$939K | 0.26% | 73 |
|
|
2019
Q3 | $1.41M | Buy |
12,601
+8,210
| +187% | +$914K | 0.11% | 192 |
|
|
2019
Q2 | $486K | Sell |
4,391
-18,972
| -81% | -$2.23M | 0.03% | 541 |
|
|
2019
Q1 | $3.03M | Buy |
+23,363
| New | +$2.84M | 0.17% | 76 |
|
|
2018
Q4 | – | Sell |
-13,267
| Closed | -$1.42M | – | 1800 |
|
|
2018
Q3 | $1.42M | Sell |
13,267
-6,229
| -32% | -$623K | 0.09% | 242 |
|
|
2018
Q2 | $1.66M | Buy |
+19,496
| New | +$1.6M | 0.1% | 216 |
|
|
2018
Q1 | – | Sell |
-35,485
| Closed | -$3M | – | 2306 |
|
|
2017
Q4 | $3M | Buy |
+35,485
| New | +$3.02M | 0.16% | 106 |
|
|
2017
Q3 | – | Sell |
-2,980
| Closed | -$245K | – | 2490 |
|
|
2017
Q2 | $245K | Sell |
2,980
-406
| -12% | -$33.1K | 0.03% | 304 |
|
|
2017
Q1 | $285K | Sell |
3,386
-13,236
| -80% | -$1.06M | 0.03% | 314 |
|
|
2016
Q4 | $1.22M | Buy |
+16,622
| New | +$1.24M | 0.13% | 124 |
|
|
2016
Q1 | – | Sell |
-3,249
| Closed | -$274K | – | 467 |
|
|
2015
Q4 | $274K | Buy |
+3,249
| New | +$270K | 0.04% | 304 |
|
|
2014
Q2 | – | Sell |
-3,740
| Closed | -$220K | – | 393 |
|
|
2014
Q1 | $220K | Buy |
+3,740
| New | +$209K | 0.03% | 348 |
|
Other funds holding LLY
Virtu Financial's LLY Position: Q1 2025 in Review
Virtu Financial sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 7,288 shares — an estimated $5.63M sold.
Virtu Financial first reported a position in LLY in Q1 2014 and held it in 23 quarters. The position peaked at $8.58M in Q3 2023. 3,921 funds tracked by Wall St. Rank hold LLY as of Q1 2025.
- Virtu Financial reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
- Virtu Financial sold 7,288 Eli Lilly shares in Q1 2025, an estimated $5.63M.
- Virtu Financial first reported a position in Eli Lilly in Q1 2014 and held it in 23 quarters.
- Virtu Financial's Eli Lilly position peaked at $8.58M in Q3 2023.
- 3,921 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.
Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.